Altium Capital Management »

Vericel shares owned by Altium Capital Management

Quarter-by-quarter ownership of Vericel (VCEL) shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Vericel

Oct 2022Jan 2023Apr 2023Jul 2023Oct 2023Jan 2024Apr 2024Jul 2024Oct 20242M2.5M70k75k80k
Value ($)Share countHistorical VCEL position of Altium Capital Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Vericel held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vericel by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.9M 68k 42.25
2022-09-30 $1.9M 80k 23.20

More positions owned by Altium Capital Management

Vera Therapeutics Cl A (VERA)
Adma Biologics (ADMA)
Sarepta Therapeutics (SRPT)
Edwards Lifesciences (EW)
Xenon Pharmaceuticals (XENE)
Zevra Therapeutics Com New (ZVRA)
Intra Cellular Therapies (ITCI)
Soleno Therapeutics (SLNO)
Glaukos (GKOS)
Insmed Com Par $.01 (INSM)
Merit Medical Systems (MMSI)
Rezolute Com New (RZLT)
Vaxcyte (PCVX)
Avadel Pharmaceuticals Com Shs (AVDL)
Viking Therapeutics (VKTX)

View all positions for Altium Capital Management

Top funds holding Vericel

BlackRock
Vanguard Group
Brown Capital Management
State Street Corporation
Invesco
FMR
Conestoga Capital Advisors
Congress Asset Management
Wellington Management Company
Jennifer Ranahan
William Blair Investment Management
Geode Capital Management
Federated Investors
Geneva Capital Management
Bnp Paribas Investment Partners

View all funds holding Vericel